NUVL Stock Analysis: Buy, Sell, or Hold?
NUVL - Nuvalent, Inc. Class A Common Stock
$123.52
0.08 (0.06%)
▲
5d:
+0.11%
30d:
+20.96%
90d:
+28.47%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When NUVL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUVL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NUVL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NUVL is currently trading at $123.52, which is considered extended relative to its 30-day fair value range of $96.24 to $122.51.
Technical Outlook: Technically, NUVL is in a uptrend. The price is currently testing key support at $123.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NUVL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUVL is in a uptrend. The price is currently testing key support at $123.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NUVL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$96.24 -
$122.51
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($128.12)
Trading Range Analysis
30-Day Trading Range
$96.24 -
$122.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$123.15
Resistance Level
$123.69
Current Trend
Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-29.88
Wall Street Target
$128.13
(+3.8%)
Share & Embed Analysis
Last updated: June 24, 2026 3:31 PM ET
Data refreshes hourly during market hours. Next update: 4:31 PM
Data refreshes hourly during market hours. Next update: 4:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Henry E Pelish
SELL
3093 shares
2026-04-09
James Richard Porter
SELL
30000 shares
2026-04-06
Alexandra Balcom
SELL
11430 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
